These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 17251680
21. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group. Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694 [Abstract] [Full Text] [Related]
26. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Ballantyne CM, Raichlen JS, Nicholls SJ, Erbel R, Tardif JC, Brener SJ, Cain VA, Nissen SE, ASTEROID Investigators. Circulation; 2008 May 13; 117(19):2458-66. PubMed ID: 18378607 [Abstract] [Full Text] [Related]
27. Cosmic effect of rosuvastatin in COSMOS. Adachi T, Ohsuzu F. Circ J; 2009 Nov 13; 73(11):2015-6. PubMed ID: 19851029 [No Abstract] [Full Text] [Related]
29. High-dose statins and atherosclerosis regression. Rozenman Y. JAMA; 2006 Oct 18; 296(15):1836; author reply 1837. PubMed ID: 17047207 [No Abstract] [Full Text] [Related]
30. High-dose statins and atherosclerosis regression. von Birgelen C, Hartmann M. JAMA; 2006 Oct 18; 296(15):1837; author reply 1837. PubMed ID: 17047210 [No Abstract] [Full Text] [Related]
31. Suppressive effects of standard-dose rosuvastatin therapy on the progression of coronary atherosclerosis in Japanese patients: the APOLLO study. Amemiya K, Yokoi H, Domei T, Shirai S, Ando K, Goya M, Iwabuchi M. J Atheroscler Thromb; 2014 Oct 18; 21(12):1298-307. PubMed ID: 25100236 [Abstract] [Full Text] [Related]
32. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. Crouse JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML, METEOR Study Group. JAMA; 2007 Mar 28; 297(12):1344-53. PubMed ID: 17384434 [Abstract] [Full Text] [Related]
37. Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials. Bayturan O, Tuzcu EM, Nicholls SJ, Balog C, Lavoie A, Uno K, Crowe TD, Magyar WA, Wolski K, Kapadia S, Nissen SE, Schoenhagen P. JACC Cardiovasc Interv; 2009 Jul 28; 2(7):672-8. PubMed ID: 19628192 [Abstract] [Full Text] [Related]
38. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial. Hibi K, Kimura T, Kimura K, Morimoto T, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Saito S, Yamaguchi T, Daida H, Matsuzaki M, JAPAN-ACS Investigators. Atherosclerosis; 2011 Dec 28; 219(2):743-9. PubMed ID: 21899843 [Abstract] [Full Text] [Related]
39. Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin. Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ. Arterioscler Thromb Vasc Biol; 2014 Nov 28; 34(11):2465-72. PubMed ID: 25212234 [Abstract] [Full Text] [Related]